Exelixis, Inc. (EXEL) stock analysis

In our weekly check, Exelixis, Inc. is graded A (A to F). Of 23 checks on debt, profit, cash flow and trend: 20 pass, warnings: 2, red flags: 1.

Sector: Healthcare · Biotechnology

Strengths

• Low debt
• Margins rising
• Profits backed by cash
• High margins
• Strong free cash flow

Warning signs

• Very volatile

Next earnings report: 2026-11-03

Similar companies

ASND · SMMT · JAZZ · HALO · BBIO · TECH

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-10

Open the full analysis